NOT KNOWN DETAILS ABOUT DCK DRUG

We subsequently produced a far more unique probe, [18F]CFA, which was used in The present examine To guage dCK exercise in tumors when addressed with a little molecule dCK inhibitor. This probe is also becoming studied in a very scientific trial at our establishment To judge improvements in dCK activity adhering to cancer immunotherapy 18. PET prob